Orforglipron may join the list of oral GLP-1s soon
Drucker said the next phase of research must include not only basic science but clinical studies that identify better treatment options and improve access
EMPA-REG OUTCOME), and dapagliflozin (The Dapagliflozin Effect on Cardiovascular Events-Thrombolysis in Myocardial Infarction 58
The first authorization, granted to Dr
Zhang and Cheng, 2022) (Table 1)
Bariatric surgery (including gastric bypass via Roux-en-Y or blind-loop intestinal bypass): Multifactorial, including systemic catabolism, steroid, tacrolimus, nutritional deficiencies (e.g., carnitine) investigation & monitoring investigation & monitoring interpreting the NH3 level This is discussed below in the treatment section